0001493152-23-006611.txt : 20230302
0001493152-23-006611.hdr.sgml : 20230302
20230302200039
ACCESSION NUMBER: 0001493152-23-006611
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230228
FILED AS OF DATE: 20230302
DATE AS OF CHANGE: 20230302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREEN DAVID
CENTRAL INDEX KEY: 0001008643
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35853
FILM NUMBER: 23701233
MAIL ADDRESS:
STREET 1: C/O HARVARD BIOSCIENCE INC
STREET 2: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746-1371
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biostage, Inc.
CENTRAL INDEX KEY: 0001563665
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 455210462
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: (774) 233-7300
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
FORMER COMPANY:
FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc.
DATE OF NAME CHANGE: 20121204
4
1
ownership.xml
X0306
4
2023-02-28
0
0001563665
Biostage, Inc.
BSTG
0001008643
GREEN DAVID
84 OCTOBER HILL RD
SUITE 11
HOLLISTON
MA
01746
1
1
0
0
CEO as of 2/28/2023
Stock Option (right to buy)
6.00
2023-02-28
4
A
0
39662
0
A
2033-02-28
Common Stock, par value $0.01 per share
39662
39662
D
Stock Option (right to buy)
6.00
2023-02-28
4
A
0
38773
0
A
2033-02-28
Common Stock, par value $0.01 per share
38773
38773
D
Stock Option (right to buy)
6.00
2023-02-28
4
A
0
732384
0
A
2033-02-28
Common Stock, par value $0.01 per share
732384
732384
D
This stock option grant was fully exercisable as of date of grant.
The non-qualified stock option was scheduled to vest during the twelve months following the grant date, but in connection with the Issuer's transition to a new CEO as of March 1, 2023, this option has been forfeited.
The non-qualified stock option was scheduled to vest monthly in thirty-six equal monthly installments on each monthly anniversary of February 28, 2023, but in connection with the Issuer's transition to a new CEO as of March 1, 2023, 488,256 shares underlying this option have been forfeited, and subject to the Reporting Person's execution of a customary release, the remaining 244,128 shares will be deemed fully vested and exercisable.
/s/ Joseph Damasio, by power of attorney
2023-03-02